Feature
Timing is everything during pandemic: How investors can ride the second wave and not drown in it
Deep Dive into global equities
A whole new world: Market recovery on the way but do not expect a return to the old normal
Deep Dive into global equities
Welcome to the #neversell era: How the latest incarnation of Nifty Fifty firms is packing a punch
Deep Dive into global equities
A shot of hope: Vaccine and cash injections could spring economy back to life by Q2
Deep Dive into global equities
In good company: Strong balance sheets offer Japanese firms resiliency during downturns
Deep Dive into Japanese equities
Artificial intelligence in healthcare: The 'do no harm' ethos must be extended to its application in the sector
Deep Dive into ESG - the tech sector
The sustainability bloc party: Will the next decade be Europe's moment to shine?
Deep Dive into ESG - the tech sector
Don't tech no for an answer: Hidden gems are just as fashionable - and more ESG-savvy - than the FAANGs
Deep Dive into ESG - the tech sector
Getting the best of both worlds: Why tech and ESG funds have more in common than what divides them
Deep Dive into ESG - the tech sector
A rock for all seasons: Gold is more than just a doomsday asset
Deep Dive into commodities
A little goes a long way: How Japan's activist shareholder evolution is slowly taking off
Deep Dive into Japanese equities
Primed for a rebound: Japanese stocks ready to flex their muscles again
Deep Dive into Japanese equities
The secret weapon? Commodities a useful addition to a multi-asset fund's armoury
Deep Dive into commodities
Value-style, growth-style or something in between? The bias conundrum for Japanese equities investors
Deep Dive into Japanese equities
AMP Capital's Mousina: Everything counts in small amounts when it comes to gold
Deep Dive into commodities
A mixed bag: Oil and metals fortunes in a constant state of flux
Deep Dive into commodities
The active manager's edge: Being mindful of ESG factors is simply good risk management
Deep Dive into corporate governance
US Election: Why pharma and other defensive sectors will provide a lifeline
Deep Dive into US Equities
Most read
